“HK Innoen’s ‘K-Cap’ is effective against NSAIDs-induced small intestine damage”
(Photo = Health Korea News D/B) (Health Korea News / Soon-ho Lee) K-CAB, a new drug for the treatment of gastroesophageal reflux disease in the potassium-competitive gastric acid secretion inhibitor (P-CAB) class developed by HK INNO.N, ingredient name: tegoprazan Research … Read more